Cognitive and motor profiles in biologically defined Parkinson's and Alzheimer's disease
Background Parkinson's disease (PD) patients may harbor coexisting Alzheimer's disease (AD) pathology that accelerates cognitive and motor decline. Defining biomarker-defined AD in PD is important for prognosis, patient counseling, and trial stratification. Objective To determine the prevalence of AD biomarker positivi...